2004
DOI: 10.1016/j.ejps.2003.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity of meningococcal PorA formulations encapsulated in biodegradable microspheres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…According to the literature and similarly to other reported methacrylates, VMA mainly couples to the 6 C of the mannose residues of the mannan side chains [18,25]. Then by the Michael addition mechanism, the thiol acting as a nucleophile reacts with grafted methacrylate (Scheme 1).…”
Section: Synthesis Of Amphiphilic Mannan-c 16mentioning
confidence: 69%
“…According to the literature and similarly to other reported methacrylates, VMA mainly couples to the 6 C of the mannose residues of the mannan side chains [18,25]. Then by the Michael addition mechanism, the thiol acting as a nucleophile reacts with grafted methacrylate (Scheme 1).…”
Section: Synthesis Of Amphiphilic Mannan-c 16mentioning
confidence: 69%
“…In the first step, methacrylated mannan was obtained by coupling HEMA-CI to mannan. A majority of HEMA groups, according to several authors, are likely coupled to the 6 C of the mannose residues of the grafts. , In the second step, the thiol acting as a nucleophile reacted with grafted methacrylate by a Michael addition mechanism, as shown in Scheme .…”
Section: Resultsmentioning
confidence: 99%
“…Controlled release devices have been used to encapsulate a large number of antigens against diseases as diverse as the plague [88,89], bacterial pneumonia [90], meningitis [91], tuberculosis [92], brucellosis [93], and anthrax [70]. On the whole, these studies demonstrate a similar adjuvant effect of controlled release devices that results in a stronger immune response, but with additional stability issues.…”
Section: Other Antigensmentioning
confidence: 96%